TNF Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets

Intangible Assets

9 Months Ended

Sep. 30, 2015

Goodwill and Intangible Assets Disclosure [Abstract]

Note 8 - Intangible Assets

Intangible assets as of September 30, 2015 and December 31, 2014 and the movements for the three months then ended are as follows:

				Distributor &
	Patents &			Customer
	Trademarks			Relationships		Totals
*Cost or Deemed Cost*
At December 31, 2014	$	3,851,495		$	1,270,639	$	5,122,134
Additions		-			-		-
Disposals		-			-		-
Impairments		(466,476	)		-		(466,476	)
At September 30, 2015	$	3,385,019		$	1,270,639	$	4,655,658

*Accumulated Amortization*
At December 31, 2014	$	1,675,430		$	1,270,639	$	2,946,069
Amortization Charge		193,929			-		193,929
Disposals		-			-		-
At September 30, 2015	$	1,869,359		$	1,270,639	$	3,139,998

*Net Book Value*
At December 31, 2014	$	2,176,065		$	-	$	2,176,065
At September 30, 2015	$	1,515,660		$	-	$	1,515,660

Amortization expense was $64,643 and $193,929 for the three and nine months ended September 30, 2015 and $64,643 and $193,929 for the three and nine months ended September 30, 2014.

Impairment expense was $466,476 for the three and nine months ended September 30, 2015 and $- for the three and nine months ended September 30. 2014.